Annie Hubbell

Annie Hubbell has over 17 years of work experience in the pharmaceutical and biotechnology industry. Annie is currently the Director of Clinical Compliance at Sage Therapeutics since August 2021. Previously, they worked as the Associate Director of Clinical Compliance at Arena Pharmaceuticals from August 2019 to July 2021. Prior to that, they held positions at Halozyme Therapeutics, Inc. as the Associate Director of Clinical Operations from July 2018 to August 2019, and as a Senior Manager of Clinical Research from August 2016 to July 2018. Annie also has experience at Dynavax Technologies as a Senior Clinical Trial Manager from January 2015 to August 2016, and as a Clinical Trial Manager from January 2014 to January 2015. Annie worked as a Senior Clinical Research Associate at Onyx Pharmaceuticals from December 2012 to January 2014, and as a Clinical Program Manager at Quark Pharmaceuticals, Inc. from December 2010 to November 2012. Annie's earlier experience includes roles at Johnson & Johnson - Ortho Biotech Oncology R&D, Baxter BioScience, Amgen, and Julia Hobbs Speech Pathology, Inc.

Annie Hubbell earned a Bachelor of Arts degree in Psychology from the University of California, Riverside. Annie attended the university from 2000 to 2004.